"Hepatitis C" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
Descriptor ID |
D006526
|
MeSH Number(s) |
C02.440.440 C02.782.350.350 C06.552.380.705.440
|
Concept/Terms |
Hepatitis C- Hepatitis C
- Parenterally-Transmitted Non-A, Non-B Hepatitis
- Parenterally Transmitted Non A, Non B Hepatitis
- PT-NANBH
- Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis C".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis C".
This graph shows the total number of publications written about "Hepatitis C" by people in this website by year, and whether "Hepatitis C" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 6 | 2 | 8 |
1998 | 4 | 0 | 4 |
1999 | 3 | 2 | 5 |
2000 | 3 | 0 | 3 |
2001 | 6 | 1 | 7 |
2002 | 2 | 1 | 3 |
2003 | 2 | 1 | 3 |
2004 | 3 | 1 | 4 |
2005 | 3 | 3 | 6 |
2006 | 4 | 1 | 5 |
2007 | 2 | 0 | 2 |
2008 | 2 | 1 | 3 |
2009 | 4 | 1 | 5 |
2010 | 6 | 1 | 7 |
2011 | 6 | 1 | 7 |
2012 | 4 | 4 | 8 |
2013 | 6 | 0 | 6 |
2014 | 7 | 2 | 9 |
2015 | 5 | 0 | 5 |
2016 | 1 | 0 | 1 |
2017 | 3 | 3 | 6 |
2018 | 8 | 1 | 9 |
2019 | 8 | 0 | 8 |
2020 | 5 | 0 | 5 |
2021 | 6 | 0 | 6 |
2022 | 8 | 0 | 8 |
2023 | 4 | 0 | 4 |
2024 | 3 | 2 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepatitis C" by people in Profiles.
-
Theoretical modeling of hepatitis C acute infection in liver-humanized mice support pre-clinical assessment of candidate viruses for controlled-human-infection studies. Sci Rep. 2024 12 30; 14(1):31826.
-
Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Harm Reduct J. 2024 Nov 29; 21(1):214.
-
Medicaid Policy and Hepatitis C Treatment Among Rural People Who Use Drugs. Med Care. 2025 Feb 01; 63(2):77-88.
-
Modes of HIV transmission among young women and their sexual partners in Ukraine. PLoS One. 2024; 19(6):e0305072.
-
Hepatitis B transmission/reactivation associated with Hepatitis B core antibody and Hepatitis C nucleic acid testing positive organs: A report from the Organ Procurement and Transplantation Network Disease Transmission Advisory Committee. Transpl Infect Dis. 2024 Nov; 26 Suppl 1:e14305.
-
Roles of epidermal growth factor receptor, claudin-1 and occludin in multi-step entry of hepatitis C virus into polarized hepatoma spheroids. PLoS Pathog. 2023 Dec; 19(12):e1011887.
-
Twelve-month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients. Transpl Infect Dis. 2024 Feb; 26(1):e14213.
-
Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis. Viruses. 2023 09 29; 15(10).
-
Development of a predictive model for identifying women vulnerable to HIV in Chicago. BMC Womens Health. 2023 06 16; 23(1):313.
-
How the rural risk environment underpins hepatitis C risk: Qualitative findings from rural southern Illinois, United States. Int J Drug Policy. 2023 02; 112:103930.